These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 21262187)

  • 1. Hormones: a potential explanation for differences in response rates to therapy for chronic hepatitis C infection.
    Forde KA; Reddy KR
    Gastroenterology; 2011 Mar; 140(3):776-9. PubMed ID: 21262187
    [No Abstract]   [Full Text] [Related]  

  • 2. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.
    Villa E; Karampatou A; Cammà C; Di Leo A; Luongo M; Ferrari A; Petta S; Losi L; Taliani G; Trande P; Lei B; Graziosi A; Bernabucci V; Critelli R; Pazienza P; Rendina M; Antonelli A; Francavilla A
    Gastroenterology; 2011 Mar; 140(3):818-29. PubMed ID: 21167831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of HCV treatment: who does well and who does not?
    Hsu CS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):846-8. PubMed ID: 20546434
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
    Bressler BL; Guindi M; Tomlinson G; Heathcote J
    Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?
    Soriano V; Martín-Carbonero L; García-Samaniego J
    AIDS; 2003 Mar; 17(5):751-3. PubMed ID: 12646800
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients.
    Lo Iacono O
    Rev Esp Enferm Dig; 2000 Aug; 92(8):485-94. PubMed ID: 11084816
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 10. What to do when standard therapy fails.
    Buti M; Esteban R
    Forum (Genova); 2000; 10(1):63-9. PubMed ID: 10717258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrosis in chronic hepatitis C infection: mechanisms and cofactors].
    Bedossa P
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B163-7. PubMed ID: 12180284
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cirrhosis due to chronic hepatitis C.
    Everson GT
    J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients.
    Granot E; Shouval D; Ashur Y
    Mediators Inflamm; 2001 Oct; 10(5):253-8. PubMed ID: 11759109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The APRI and the RVR.
    Snyder N; Petersen JR
    J Clin Gastroenterol; 2009; 43(5):500-1. PubMed ID: 19098684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic hepatitis C and alcohol consumption].
    Mathurin P; Canva V; Dharancy S; Paris JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B248-51. PubMed ID: 12180297
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of chronic hepatitis C.
    Lo Re V; Kostman JR
    Postgrad Med J; 2005 Jun; 81(956):376-82. PubMed ID: 15937203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis C].
    Grammatikos G; Sarrazin C
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?
    Navasa M; Forns X
    J Hepatol; 2007 Feb; 46(2):185-8. PubMed ID: 17161494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.